Ex Pharma CEO Gets Prison Time for Kickbacks

A former executive at Omaha’s Pharmaceutical Technologies Inc. will pay a hefty fine and serve time for agreeing to millions in illegal kickbacks to representatives.

Douglas M. Pick, former president and CEO of PTI / Image: Creighton University
Douglas M. Pick, former president and CEO of PTI / Image: Creighton University

A recent Omaha World-Herald article noted the sentence handed down to Douglas M. Pick for unethical behavior in the pharmaceutical industry. Pick served as president and CEO of Omaha-based Pharmaceutical Technologies Inc. (PTI) from 1992 to 2013. During that time, he agreed to hand out $3.5 million in kickbacks to representatives of pharmacy benefit plans in exchange for business.

The money came from fees added to prescriptions paid by customers that were then funneled to a shell company set up by an executive of the hospital. Peck was sentenced to a year and a day in prison, a $50,000 fine, and roughly $350,000 in restitution. PTI avoided prosecution by cooperating with the Justice Department’s investigation and agreeing to pay more than $8.5 million.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report